4c4f: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1== | ==Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1== | ||
<StructureSection load='4c4f' size='340' side='right' caption='[[4c4f]], [[Resolution|resolution]] 2.36Å' scene=''> | <StructureSection load='4c4f' size='340' side='right'caption='[[4c4f]], [[Resolution|resolution]] 2.36Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4c4f]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4C4F OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4C4F FirstGlance]. <br> | <table><tr><td colspan='2'>[[4c4f]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4C4F OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4C4F FirstGlance]. <br> | ||
| Line 30: | Line 30: | ||
[[Category: Dual-specificity kinase]] | [[Category: Dual-specificity kinase]] | ||
[[Category: Human]] | [[Category: Human]] | ||
[[Category: Large Structures]] | |||
[[Category: Atrash, B]] | [[Category: Atrash, B]] | ||
[[Category: Baker, R]] | [[Category: Baker, R]] | ||